Paul Lizzul
2022
In 2022, Paul Lizzul earned a total compensation of $3.8M as Chief Medical Officer at ANAPTYSBIO.
Compensation breakdown
| Non-Equity Incentive Plan | $174,544 |
|---|---|
| Option Awards | $2,872,730 |
| Salary | $471,740 |
| Stock Awards | $283,440 |
| Other | $10,074 |
| Total | $3,812,528 |
Lizzul received $2.9M in option awards, accounting for 75% of the total pay in 2022.
Lizzul also received $174.5K in non-equity incentive plan, $471.7K in salary, $283.4K in stock awards and $10.1K in other compensation.
Rankings
In 2022, Paul Lizzul's compensation ranked 918th out of 5,542 executives tracked by ExecPay. In other words, Lizzul earned more than 83.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 918 out of 5,542 | 83rd |
Division Manufacturing | 419 out of 3,000 | 86th |
Major group Chemicals And Allied Products | 150 out of 1,350 | 89th |
Industry group Drugs | 136 out of 1,253 | 89th |
Industry Pharmaceutical Preparations | 101 out of 907 | 89th |
Source: SEC filing on April 24, 2024.
Lizzul's colleagues
We found two more compensation records of executives who worked with Paul Lizzul at ANAPTYSBIO in 2022.